XML 65 R51.htm IDEA: XBRL DOCUMENT
v3.21.2

SEGMENT INFORMATION (Tables) | 12 Months Ended
--- | ---
Oct. 31, 2021
Revenue from External Customer [Line Items] |
Segment profitability | The profitability of each of the segments is measured after excluding items such as asset impairment charges, transformational initiatives, acquisition and integration costs, non-cash amortization of intangible assets related to business combinations, interest income, interest expense, and other items as noted in the reconciliations below.
| Life Sciences and Applied Markets |  | Diagnostics and Genomics |  | Agilent CrossLab |  | Total Segments
| (in millions)
Year Ended October 31, 2021: |  |  |  |  |  |  |
Total net revenue | $ | 2,823 |  |  | $ | 1,296 |  |  | $ | 2,200 |  |  | $ | 6,319 |
Income from operations | $ | 722 |  |  | $ | 273 |  |  | $ | 618 |  |  | $ | 1,613 |
Depreciation expense | $ | 44 |  |  | $ | 39 |  |  | $ | 39 |  |  | $ | 122 |
Share-based compensation expense(1) | $ | 45 |  |  | $ | 22 |  |  | $ | 39 |  |  | $ | 106 |
Year Ended October 31, 2020: |  |  |  |  |  |  |
Total net revenue | $ | 2,392 |  |  | $ | 1,047 |  |  | $ | 1,900 |  |  | $ | 5,339 |
Income from operations | $ | 548 |  |  | $ | 192 |  |  | $ | 516 |  |  | $ | 1,256 |
Depreciation expense | $ | 43 |  |  | $ | 39 |  |  | $ | 37 |  |  | $ | 119 |
Share-based compensation expense (1) | $ | 35 |  |  | $ | 17 |  |  | $ | 29 |  |  | $ | 81 |
Year Ended October 31, 2019: |  |  |  |  |  |  |
Total net revenue | $ | 2,302 |  |  | $ | 1,021 |  |  | $ | 1,840 |  |  | $ | 5,163 |
Income from operations | $ | 542 |  |  | $ | 185 |  |  | $ | 475 |  |  | $ | 1,202 |
Depreciation expense | $ | 41 |  |  | $ | 35 |  |  | $ | 35 |  |  | $ | 111 |
Share-based compensation expense | $ | 33 |  |  | $ | 14 |  |  | $ | 25 |  |  | $ | 72 |
(1) Share-based compensation expense in 2020 and 2021 excludes amounts not allocated to the segments related to accelerated share-based compensation expense from workforce reduction and from our acquisition of BioTek and Resolution Bioscience.
Reconciliation of segment results to total enterprise results | The following table reconciles reportable segments' income from operations to Agilent's total enterprise income before taxes:
| Years Ended October 31,
| 2021 |  | 2020 |  | 2019
| (in millions)
Total reportable segments' income from operations | $ | 1,613 |  |  | $ | 1,256 |  |  | $ | 1,202 |
Amortization of intangible assets related to business combinations | (194) |  |  | (184) |  |  | (125) |
Acquisition and integration costs | (41) |  |  | (41) |  |  | (48) |
Transformational initiatives | (37) |  |  | (53) |  |  | (44) |
Acceleration of share-based compensation expense related to workforce reduction | (1) |  |  | (2) |  |  | — |
Asset impairments | (2) |  |  | (99) |  |  | — |
Business exit and divestiture costs | (5) |  |  | (2) |  |  | — |
Change in fair value of contingent consideration | 21 |  |  | — |  |  | — |
NASD site costs | — |  |  | — |  |  | (12) |
Special compliance costs | (1) |  |  | — |  |  | (2) |
Other (1) | (6) |  |  | (29) |  |  | (30) |
Interest Income | 2 |  |  | 8 |  |  | 36 |
Interest Expense | (81) |  |  | (78) |  |  | (74) |
Other income (expense), net (2) | 92 |  |  | 66 |  |  | 16 |
Income before taxes, as reported | $ | 1,360 |  |  | $ | 842 |  |  | $ | 919 |
(1) For the years ended October 31, 2020 and 2019, the other category primarily includes legal costs related to a claim we pursued against Twist Bioscience Corporation in addition to other miscellaneous adjustments. (2) For the year ended October 31, 2021, other income (expense), net includes net gains on the fair value of equity securities. For the year ended October 31, 2020, other income (expense), net includes the settlement of a legal claim against Twist Bioscience Corporation.
Assets and capital expenditures directly managed by each segment | The following table reflects segment assets and capital expenditures under our management reporting system. Segment assets include allocations of corporate assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, short-term and long-term investments, deferred tax assets, right-of use assets and other assets.
| Life Sciences and Applied Markets |  | Diagnostics and Genomics |  | Agilent CrossLab |  | Total Segments
| (in millions)
As of and for the Year Ended October 31, 2021: |  |  |  |  |  |  |
Assets | $ | 3,078 |  |  | $ | 3,320 |  |  | $ | 1,502 |  |  | $ | 7,900 |
Capital expenditures | $ | 45 |  |  | $ | 100 |  |  | $ | 43 |  |  | $ | 188 |
As of and for the Year Ended October 31, 2020: |  |  |  |  |  |  |
Assets | $ | 3,143 |  |  | $ | 2,515 |  |  | $ | 1,375 |  |  | $ | 7,033 |
Capital expenditures | $ | 44 |  |  | $ | 34 |  |  | $ | 41 |  |  | $ | 119 |
The following table reconciles segment assets to Agilent's total assets:
| October 31,
| 2021 |  | 2020
| (in millions)
Total reportable segments' assets | $ | 7,900 |  |  | $ | 7,033 |
Cash and cash equivalents | 1,484 |  |  | 1,441 |
Short-term investments | 91 |  |  | — |
Prepaid expenses | 91 |  |  | 106 |
Long-term investments | 185 |  |  | 158 |
Long-term and other receivables | 126 |  |  | 114 |
Deferred tax assets | 309 |  |  | 380 |
Right of use assets | 178 |  |  | 175 |
Other | 341 |  |  | 220 |
Total assets | $ | 10,705 |  |  | $ | 9,627 |
The other category primarily includes overfunded pension plans which are not allocated to the segments.
Revenue and assets by geographic areas | The following table presents summarized information for net revenue by geographic region. Revenues from external customers are generally attributed to countries based upon the customers' location.
| United States |  | China(1) |  |  |  | Rest of the World |  | Total
| (in millions)
Net revenue: |  |  |  |  |  |  |  |  |
Year Ended October 31, 2021 | $ | 2,159 |  |  | $ | 1,273 |  |  |  |  | $ | 2,887 |  |  | $ | 6,319 |
Year Ended October 31, 2020 | $ | 1,752 |  |  | $ | 1,087 |  |  |  |  | $ | 2,500 |  |  | $ | 5,339 |
Year Ended October 31, 2019 | $ | 1,619 |  |  | $ | 1,019 |  |  |  |  | $ | 2,525 |  |  | $ | 5,163 |
1. China also includes Hong Kong net revenue. The following table presents summarized information for long-lived assets by geographic region. Long lived assets consist of property, plant, and equipment, right-of-use assets, long-term receivables and other long-term assets excluding intangible assets. The rest of the world primarily consists of Asia and the rest of Europe.
| United States |  |  |  | Germany |  | Rest of the World |  | Total
| (in millions)
Long-lived assets: |  |  |  |  |  |  |  |  |
October 31, 2021 | $ | 912 |  |  |  |  | $ | 134 |  |  | $ | 587 |  |  | $ | 1,633 |
October 31, 2020 | $ | 727 |  |  |  |  | $ | 126 |  |  | $ | 538 |  |  | $ | 1,391 |

X
- Definition Tabular disclosure of the total assets and capital expenditures for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References No definition available. + Details
Name: | a_AssetsAndCapitalExpendituresDirectlyManagedByEachSegmentTableTextBlock
Namespace Prefix: | a_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599 + Details
Name: | us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227 + Details
Name: | us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration